|
NDUFB10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00609998110457E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.89140003448563E-09 |
| Normal-vs-Stage2 |
1.355500E-02 |
| Normal-vs-Stage3 |
1.662380E-03 |
| Normal-vs-Stage4 |
5.697800E-02 |
| Stage1-vs-Stage2 |
4.539900E-02 |
| Stage1-vs-Stage3 |
7.680600E-01 |
| Stage1-vs-Stage4 |
7.573400E-01 |
| Stage2-vs-Stage3 |
2.353400E-01 |
| Stage2-vs-Stage4 |
4.115200E-01 |
| Stage3-vs-Stage4 |
9.018200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.08119982253652E-10 |
| Normal-vs-AfricanAmerican |
2.395900E-04 |
| Normal-vs-Asian |
7.408200E-01 |
| Caucasian-vs-AfricanAmerican |
6.075200E-01 |
| Caucasian-vs-Asian |
1.781360E-01 |
| AfricanAmerican-vs-Asian |
2.820400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22239995903328E-10 |
| Normal-vs-Female |
3.562300E-03 |
| Male-vs-Female |
5.958300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.557300E-03 |
| Normal-vs-Extreme_Weight |
2.69139999176105E-09 |
| Normal-vs-Obese |
1.429100E-04 |
| Normal-vs-Extreme_Obese |
7.419500E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.531600E-02 |
| Normal_Weight-vs-Obese |
4.027200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.675000E-01 |
| Extreme_Weight-vs-Obese |
2.811000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.481800E-01 |
| Obese-vs-Extreme_Obese |
8.038600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.517400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.35999999997905E-06 |
| Normal-vs-Age(61-80Yrs) |
1.09169995266001E-09 |
| Normal-vs-Age(81-100Yrs) |
1.138500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.058000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.610400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.239800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.798000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.872000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.473790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.16320286736027E-11 |
| Normal-VS-Type2 PRCC |
5.181600E-04 |
| Normal-VS-KIRP CIMP |
9.885000E-01 |
| Normal-VS-Unclassified PRCC |
4.756100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.747600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.796260E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.858800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.252820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.479400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.085570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.788100E-04 |
| Normal-vs-N1 |
4.401500E-02 |
| Normal-vs-N2 |
9.701600E-01 |
| N0-vs-N1 |
2.687200E-01 |
| N0-vs-N2 |
2.440000E-01 |
| N1-vs-N2 |
3.785600E-01 |
|
|
